In addition, higher expression levels of COLEC12, S100A9, TREM1 and lower expression level of IFIT1 were associated with poor response to immunotherapy in patients with HCC, suggesting that these IRGs probably affect the efficacy of ICI in HCC patients (Figures 6O–R). Here, IFIT1 is linked to hepatocellular carcinoma.